Comparison of Dexmedetomidine and Remifentanil Infusion During CABG
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
We are trying to investigate whether intraoperative dexmedetomidine infusion could decrease
the incidence of intraoperative hypokalemia and arrhythmia, and myocardial injury in patients
undergoing off-pump coronary artery bypass graft, and trying compare these effects with those
of remifentanil infusion.